DRG:HYBRiD-XL: Celiac Diseases

DRG is proud to announce the launch of 4 new assays for the fully automated diagnosis and monitoring of Coeliac Diseases on DRG:HYBRiD-XL®

These test systems are intended for the quantitative determination of IgA or IgG antibodies in human serum/plasma samples.

Anti-tissue Transglutaminase:

• Anti-tTG IgA  HYE-5894
• Anti-tTG IgG  HYE-5895

Anti-Deamidated Gliadin Peptide:

• Anti-DGP IgA  HYE-5819
• Anti-DGP IgG  HYE-5820

Clinical Application:

• Diagnosis and monitoring of Coeliac Diseases
• Useful application for diagnosing children

Clear advantages:

• High sensitivity and good specificity
• Fully automated sample dilution
• Good assay performance (validated according to CLSI guidelines)
• Two controls and two re-calibrators included and ready to use